Stocks gain as financials bounce, but Nasdaq lags as biotechs plunge
Permalink

Stocks gain as financials bounce, but Nasdaq lags as biotechs plunge

The two weakest Dow stocks were Merck, down 2.2 per cent, and Pfizer, down 1.3…

Continue Reading →

Wall Street rebounds with financials; biotechs drop
Permalink

Wall Street rebounds with financials; biotechs drop

Hillary Clinton’s tweet about the “outrageous” prices for biotech drugs sent the Nasdaq spiraling lower…

Continue Reading →

Advertisement

Diet blamed after obese girl (3) is diagnosed with Type 2 illness
Permalink

Diet blamed after obese girl (3) is diagnosed with Type 2 illness

A study of 6,467 children from England found that no garden access for lower educated…

Continue Reading →

Merck’s Ebola vaccine proves effective
Permalink

Merck’s Ebola vaccine proves effective

The trial was started by the Public Health Agency of Canada and then developed by…

Continue Reading →

Strong dollar weighs on Merck revenue
Permalink

Strong dollar weighs on Merck revenue

The package and delivery service posted revenue of $14.1 billion in the period, falling short…

Continue Reading →

Advertisement

Guinea Plans Ebola Inoculation Campaign After Vaccine Success
Permalink

Guinea Plans Ebola Inoculation Campaign After Vaccine Success

Despite the remarkable results, officials at the WHO believe the effectiveness of the vaccine is…

Continue Reading →

Global Fund For Vaccines Can Prevent Outbreak Of Deadly Diseases
Permalink
Initial results show Ebola vaccine ‘highly effective’
Permalink

Initial results show Ebola vaccine ‘highly effective’

VSV-ZEBOV was originally developed by Canada’s public health agency before being licensed to NewLink Genetics,…

Continue Reading →

Merck & Co. Downgraded to “Buy” at Vetr Inc. (MRK)
Permalink

Merck & Co. Downgraded to “Buy” at Vetr Inc. (MRK)

Analysts are projecting that Merck & Company, Inc. will report earnings per share of $0.8…

Continue Reading →

Merck raises forecast on strong sales of diabetes, cancer drugs
Permalink

Merck raises forecast on strong sales of diabetes, cancer drugs

SuperValu Inc. (SVU) on Tuesday reported fiscal first-quarter profit of $61 million.

Continue Reading →